PubMed Health⌕ Search

PubMed · 11381539

Organic halide electroreduction on silver.

Abstract

Silver, whose extraordinary electrocatalytical properties for organic halide reduction have been recently evidenced, has been used as cathode material for systematic preparative electrolyses in membrane-divided cells. To better elucidate the substrate role on the remarkable positive shift of reduction potentials, and on the "cage effect" i.e. the promotion of intermolecular reaction on adsorbed intermediates, three halide substrate patterns are here compared in terms of both voltammetric characterization and preparative electroreduction products: aliphatic halides (adamantanes), aromatic halides (phenols) and anomeric glycosyl halides. The preparative electroreductions result mainly in dimerization in the case of glycosyl halides, in H-->Br substitution in the case of bromophenols, in dimerization + substitution in the case of haloadamantanes. The product analysis, both at the end of the reaction and at intermediate times, allows discussing the reaction pathways in terms of intermediate stability and of active surface accessibility. The possibility of complete dehalogenation on a wider substrate variety with remarkably lower energy consumption and almost quantitative current yields makes the process potentially very interesting for environmental purposes.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

G Fiori, P R Mussini, S Rondinini, A Vertova. Organic halide electroreduction on silver.. https://pubmed.ncbi.nlm.nih.gov/11381539/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Effects of cholecystokinin tetrapeptide (CCK(4)) and of anxiolytic drugs on GABA outflow from the cerebral cortex of freely moving rats.

The effect of cholecystokinin tetrapeptide (CCK(4)) and of different anxiolytic drugs on GABA outflow from the cerebral cortex was investigated in freely moving rats, by using the epidural cup technique. CCK(4) (3-30 microg/kg, i.p.) increased GABA outflow and induced objective signs of anxiety. These neurochemical and behavioral responses were prevented by the CCK(B) antagonist GV150013 at 0.1 microg/kg (i.p.). At higher doses (up to 30 microg/kg) this compound per se reduced GABA release and caused sedation, suggesting the presence of a CCKergic positive tonic modulation on GABA interneurons. Similarly the GABA(A) receptors modulator, diazepam (2mg/kg, i.p.) and the 5-HT(1A) agonist buspirone (3mg/kg, i.p.) reduced GABA outflow and caused the expected behavioral effects (reduced muscle tone, mild 5-HT syndrome) which were prevented by the respective, selective antagonists, flumazenil (1mg/kg, i.p.) and NAN-190 (3mg/kg, i.p.). These findings support the idea that GV150013, diazepam and buspirone inhibit GABAergic cortical activity, through the respective receptors. This neurochemical effect may represent the end-effect of various anxiolytic compounds affecting the cortical circuitry.

Adamantane↗

Nanoscale 1,3,5,7-tetrasubstituted adamantanes and p-substituted tetraphenyl-methanes for AFM applications.

[structure: see text] Tetrahedrally shaped nanoscale molecules 18-20 were synthesized from the corresponding tetraiodide by a series of Sonogashira coupling reactions. Three of the sulfur-containing termini are intended for eventual binding to a gold-coated conventional AFM tip, while the fourth terminus scans the sample. AFM images of 19 demonstrate that the molecule is sufficiently large and rigid to be imaged by a conventional AFM tip.

Adamantane↗